DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

New MR imaging technique doesn't require use of contrast agents Detects 98 percent of malignant breast lesions

Ultrasound with 'cheap' blood test improves early-stage liver cancer detection by 40 percent May become standard practice

FDA clears the Arterys Oncology AI suite Designed for liver MR and CT and lung CT

Tomo associated with fewer false positives than digital mammo, study finds To be presented at ARRS annual meeting

Congress freezes radiation treatment payment rates for free-standing clinics through 2019 ASTRO applauds

Study finds PSMA PET/CT can identify early prostate cancer recurrence Already a standard in Europe

RaySearch to supply RayStation to first proton therapy center in India Set to begin treating patients in September 2018

New paper brings attention to heart disease risk associated with breast cancer treatment Especially affects those over 65

SCOUT Radar Localization System in use at 230 U.S. hospitals Cianna Medical system has been used for over 25,000 breast tumor localizations

Varian acquires Mobius Medical Systems Will expand the company's QA software portfolio

For this cancer, proton therapy is no better than IMRT

by John R. Fischer , Staff Reporter
Proton therapy (PT) may not be a safer bet compared to conventional radiation when it comes to lowering toxicity associated with non-small cell lung cancer (NSCLC).

At least that’s what researchers at the University of Texas MD Anderson Cancer Center and Massachusetts General Hospital say in a new study comparing dose distribution of 3-D passive scattering proton therapy (PT) and intensity-modulated radiation therapy (IMRT), finding no decline in risks, such as radiation pneumonitis, when using the former type of treatment. Their findings were published in the Journal of Clinical Oncology.

Story Continues Below Advertisement

Ventilators Plus -The Easy #1 Choice In Ventilator Sales, Rentals & Support

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY, SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7. Call 888-889-2992.



“There is no doubt that there is dosimetric advantage in protons compared with photons. Whether the dosimetric advantage will translated to clinical benefit or not depends on many factors including how best use this new form of radiation," Dr. Zhongxing Liao, the lead author of the study and a professor of Radiation Oncology at the University of Texas MD Anderson Cancer Center, told HCB News. "Our trial showed that, using an outdated way, passively scattered proton beam or 3-D conformal proton, to deliver proton, we were not able to realize the dosimetric advantage of the proton on lung; therefore, we did not reduce radiation pneumonitis."

The presumption that proton therapy is superior to conventional radiation due to its more-targeted form of delivery have led some to conclude that randomized trials comparing the two are unnecessary, inappropriate and unethical.

Researchers tested this hypothesis in a Bayesian trial in which 149 patients with inoperable NSCLC were randomly selected to undergo IMRT or PSPT with the objective being to determine if PSPT patients showed a lower risk of grade ≥ 3 RP or local failure (LF).

PSPT was found to expose less lung tissue at 5-10 GY (RBE) doses but more at doses of 20 GY (RBE) or higher. No benefits in grade ≥ 3 RP or LF were found in these patients with locally advanced NSCLC.

A one-year follow-up found the PSPT group had a 10.5 percent rate of ≥ 3 RP compared with 6.5 percent of IMRT patients.

Rates of LF were 10.9 percent at one year for patients who underwent IMRT, compared to 10.5 percent of PSPT patients. Combined RP and LF rates at one year were 17.4 percent and 21.1 percent following IMRT and PSPT, respectively.

Though not the main focus, median survival for PSPT patients was 26.1 months and for IMRT, 29.5.

The findings here could make many skeptical of growth predictions for the proton therapy market, which is expected to almost double in value by 2022. They also contrast with a recent study that compared PT and IMRT in the treatment of prostate cancer, finding higher survival rates and less complications induced by radiation exposure among patients who underwent PT.

“The trial tells us that, when investing for proton centers, one needs to be aware of the issues encountered in our trial and be prepared to address them," said Liao. "Adequate engineering, physics, clinical and research support is critical to ensure the success of the proton centers.”

Despite these results, the use of PSPT was found to reduce heart exposure to radiation at levels between 5 and 80 Gy, as well as heart volume, with its impact on cardiac toxicity and overall survival currently under study.

Sparing the heart for overall survival is currently being evaluated in a phase III randomized lung trial that will provide evidence on the use of proton therapy for lung cancer, while a phase II study is comparing the effects of IMRT to the next-generation proton technique intensity-modulated proton therapy. Both will help in providing more information on the comparisons between proton therapy and photon treatments.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED